{"prompt": "['Alliance A171601', 'Vomiting', 'Vomiting', 'Gastrointestinal disorders', 'Mucositis oral', 'Mouth/throat sores', 'Gastrointestinal disorders', 'Fatigue', 'Fatigue', 'General disorders', 'Peripheral Sensory', 'Numbness and Tingling', 'General disorders', 'Neuropathy', 'Thromboembolic event', 'Vascular disorders', 'Upper Respiratory Infection', 'Infections and Infestations', 'Urinary Tract Infection', 'Infections and Infestations', '9.2', 'CTCAE Routine Reporting Requirements', 'In addition to the solicited adverse events listed in Section 9.1, the following table outlines the', 'combinations of time points, grades and attributions of AEs that require routine reporting to the', 'Alliance Statistics and Data Center. Questions about routine reporting should be directed to the', 'Data Manager. PRO-CTCAE data should not be used for determining attribution, dose', 'modifications, or reporting of serious adverse events.', 'Combinations of CTCAE Grade & Attribution Required for Routine AE Data', 'Submission on Case Report Forms (CRFs)', 'Attribution', 'Grade 1', 'Grade 2', 'Grade 3', 'Grade 4', 'Grade 5', 'Unrelated', 'a', 'a', 'a', 'a', 'Unlikely', 'a', 'a', 'a', 'a', 'Possible', 'a', 'a, b', 'a, b', 'a, b', 'Probable', 'a', 'a, b', 'a, b', 'a, b', 'Definite', 'a', 'a, b', 'a, b', 'a, b', 'a)', 'Adverse Events: Other CRF - Applies to AEs occurring between registration and', \"within 30 days of the patient's last treatment date, or as part of the Clinical Follow - Up\", 'Phase.', 'b) Adverse Events: Late CRF - Applies to AEs occurring greater than 30 days after', \"the patient's last treatment date.\", '9.3', 'Expedited Adverse Event Reporting (CTEP-AERS)', 'Investigators are required by Federal Regulations to report serious adverse events as defined in', 'the table below. Alliance investigators are required to notify the Alliance Central Protocol', 'Operations Program, the Study Chair, and their Institutional Review Board if a patient has a', 'reportable serious adverse event. The descriptions and grading scales found in the NCI Common', 'Terminology Criteria for Adverse Events (CTCAE) version 5 will be utilized for AE reporting.', 'The', 'CTCAE', 'is', 'identified', 'and', 'located', 'on', 'the', 'CTEP', 'website', 'at:', 'All', 'appropriate', 'treatment areas should have access to a copy of the CTCAE. All reactions determined to be', '\"reportable\" in an expedited manner must be reported using the Cancer Therapy Evaluation', 'Program Adverse Event Reporting System (CTEP-AERS).', '37', 'NCI Version Date: 5/29/2020', 'Update 5']['Alliance A171601', 'For further information on the NCI requirements for SAE reporting, please refer to the \"NCI', \"Guidelines for Investigators: Adverse Event Reporting Requirements' document published by\", 'the NCI.', 'Note: All deaths on study require both routine and expedited reporting regardless of causality.', 'Attribution to treatment or other cause should be provided.', '38', 'NCIVersion Date: 5/29/2020', 'Update 5']\n\n###\n\n", "completion": "END"}